| |
Veröffentlichungen zum Thema:
Piel, M., Schirrmacher, R., Höhnemann, S., Hamkens, W., Kohl,
B.K., Jansen, M., Schmitt, U., Lüddens, H., Dannhardt, G.,
Rösch, F.:
Synthesis and evaluation of 5,7-dichloro-4-(3-{4-[4-(2-[18F]fluoroethyl)-
piperazin-1-yl]-phenyl}-ureido)-1,2,3,4-tetrahydroquinoline-2-carboxylic
acid as a potential NMDA ligand to study glutamatergic neurotransmission
in vivo, J. Label Compd Radiopharm 2003, 46; 645-659
Jansen,
M.; Potschka, H.; Brandt, C.; Dannhardt, G.; Löscher, W. Hydantoin
substituted 4,6-dichloroindole-2-carboxylic Acids as Ligands with
high affinity for the Glycine Binding Site of the NMDA Receptor,
J. Med. Chem.
2003,
46;
64-73
Kohl, B.K.; Dannhardt, G.:
The NMDA Receptor Complex: A Promising Target for Novel Antiepileptic
Strategies, Curr. Med. Chem.
2001;
8; 1275-1289
Dannhardt, G.; Kohl, B.K.; Benzimidazoles as
ligands for the glycine-site of the NMDA receptor: Synthesis, radioligand
and binding-studies and structure-activity relationships, Pharm.
Pharmacol. Lett. 2000;
10; 1-4
Dannhardt, G.; von Gruchalla, M.; Kohl, B.K.;
Parsons, C.G.: A Novel Series of 2-Carboxytetrahydroquinolines provides
New Insights into the Eastern Region of Glycine Site NMDA Antagonists,
Arch. Pharm. Pharm. Med. Chem.
2000;
333; 267-274
Dannhardt, G.; v. Gruchalla, M.; Herkert, M.:
Tools for NMDA-receptor elucidation: Synthesis and binding affinities
of (+)-MK-801 derivatives designed for detection and purification
of the receptor protein. Pharm. Pharmacol. Lett.
1998;
8; 11-15
Dannhardt, G.; Kohl, B. K.; The gylcine site
on the NMDA receptor: structure-activity relationships and possible
therapeutic applications. Curr. Med. Chem.
1998;
5;
253-263
Dannhardt, G.; v. Gruchalla, M.; Elben, U.:
Tools for NMDA-receptor elucidation: Synthesis of spacer-coupled
MK-801 derivatives. Pharrn. Pharmacol. Lett.
1994;
12-15
Dannhardt, G.; v. Gruchalla, M.; Elben, U; Herkert,
M.: Tools for NMDA-receptor elucidation: Binding affinities of spacer-coupled
MK-801 derivatives. Pharm. Pharmacol. Lett.
1994;
16-18
|
|